Optilume drug-coated balloon dilation for treatment of post-prostate cancer ablative therapy urethral stricture: a case series.

ABSTRACT:

Background

Optilume-drug coated balloon as emerged as a less invasive management of recurrent bulbar urethral strictures. Data is still emerging in terms of its efficacy with regards to other stricture types. Additionally, ablative therapies (whether focal or whole gland) are also becoming more common for management of prostate cancer. As these treatments progress, we, as a specialty, will see more complications from these to include urethral strictures. This series demonstrates the use of the Optilume drug-coated balloon (DCB) dilation system for the treatment of urethral stricture disease after prostate ablative therapy for treatment of prostate cancer.

Case description

Two patients involved men who had focal therapy with transurethral ultrasound ablation (TULSA) for treat

SUBMITTER: Hertz A 

PROVIDER: S-EPMC12541494 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature